pe
pep-05371 v1 CC-BY-SA-4.0

Penaeidin-4a anticancer peptide

A peptide studied in the lab for its potential to fight cancer cells; experimental, not yet an approved drug.

statuscomputed targetANTICANCER length47 aa refs3
anticancer
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.445
avg pLDDT58.9
ranking score0.560
STRUCTURE · PEP-05371 × ANTICANCER
ranking0.560
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence47 aa
15101520253035404547
HSSGYTRPLPKPSRPI FIRPIGCDVCYGIPSS TARLCCFRYGDCCHR
in the news 27 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.5603753328323364 boltz-2
3-letter notation
His-Ser-Ser-Gly-Tyr-Thr-Arg-Pro-Leu-Pro-Lys-Pro-Ser-Arg-Pro-Ile-Phe-Ile-Arg-Pro-Ile-Gly-Cys-Asp-Val-Cys-Tyr-Gly-Ile-Pro-Ser-Ser-Thr-Ala-Arg-Leu-Cys-Cys-Phe-Arg-Tyr-Gly-Asp-Cys-Cys-His-Arg
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). Penaeidin-4a anticancer peptide (pep-05371, v1). PeptideModel. https://peptidemodel.com/card/pep-05371
@peptide{pep05371,
  sequence = {HSSGYTRPLPKPSRPIFIRPIGCDVCYGIPSSTARLCCFRYGDCCHR},
  target   = {anticancer},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
related peptides 5 by signal overlap
references 3 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use